South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.

South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...

Also, the FDA approved Merilog’s 3-milliliter single-patient-use prefilled pen and a 10-milliliter ... rely on daily injections of insulin for treatment of diabetes, having a biosimilar option ...

Q: I saw an advertisement in a magazine for a needle-free insulin pen. Can you tell me more about how this works and is it ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Quality scores dipped during the COVID-19 pandemic, but are now at or above 2019 levels in areas such as diabetes and asthma management.

"There’s been a real shortage of these products, particularly since they share production with, for example, the diabetes and weight-loss products." Aspen is adding the ability to make pens and may ...

After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 ...

the diabetes and weight-loss products.” Aspen is adding the ability to make pens and may yet get rights to manufacturer insulin pens, Saad added. South Africa’s regulator has also been called ...